The impact of heart rate-based drowsiness monitoring on adverse driving events in heavy vehicle drivers under naturalistic conditions.


Journal

Sleep health
ISSN: 2352-7226
Titre abrégé: Sleep Health
Pays: United States
ID NLM: 101656808

Informations de publication

Date de publication:
06 2020
Historique:
received: 28 05 2019
revised: 28 02 2020
accepted: 10 03 2020
pubmed: 29 4 2020
medline: 16 1 2021
entrez: 29 4 2020
Statut: ppublish

Résumé

This study examined the influence of a wrist-worn heart rate drowsiness detection device on heavy vehicle driver safety and sleep and its ability to predict driving events under naturalistic conditions. Prospective, non-randomized trial. Naturalistic driving in Malaysia. Heavy vehicle drivers in Malaysia were assigned to the Device (n = 25) or Control condition (n = 34). Both conditions were monitored for driving events at work over 4-weeks in Phase 1, and 12-weeks in Phase 2. In Phase 1, the Device condition wore the device operated in the silent mode (i.e., no drowsiness alerts) to examine the accuracy of the device in predicting driving events. In Phase 2, the Device condition wore the device in the active mode to examine if drowsiness alerts from the device influenced the rate of driving events (compared to Phase 1). All participants were monitored for harsh braking and harsh acceleration driving events and self-reported sleep duration and sleepiness daily. There was a significant decrease in the rate of harsh braking events (Rate ratio = 0.48, p < 0.05) and a fall in subjective sleepiness (p < 0.05) when the device was operated in the active mode (compared to the silent mode). The device predicted when no driving events were occurring (specificity=98.81%), but had low accuracy in detecting when a driving event did occur (sensitivity=6.25%). Including drowsiness detection devices in fatigue management programs appears to alter driver behaviour, improving safety despite the modest accuracy. Longer term studies are required to determine if this change is sustained.

Identifiants

pubmed: 32340910
pii: S2352-7218(20)30103-0
doi: 10.1016/j.sleh.2020.03.005
pii:
doi:

Types de publication

Controlled Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

366-373

Informations de copyright

Copyright © 2020 National Sleep Foundation. Published by Elsevier Inc. All rights reserved.

Auteurs

Alexander P Wolkow (AP)

Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, 18 Innovation Walk, Clayton, VIC, Australia.

Shantha M W Rajaratnam (SMW)

Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, 18 Innovation Walk, Clayton, VIC, Australia.

Vanessa Wilkinson (V)

Institute for Breathing and Sleep, Department of Respiratory and Sleep Medicine, Austin Health, 145 Studley Road, PO Box 5555, Heidelberg, VIC, Australia.

Dexter Shee (D)

Neurobusiness Behavioural Laboratory, Monash University Malaysia, Building 6B, Kuala Lumpur, Malaysia.

Angela Baker (A)

Shell International, Carel van Bylandtlaan 16, The Hague, the Netherlands.

Teri Lillington (T)

Shell International, Carel van Bylandtlaan 16, The Hague, the Netherlands.

Peter Roest (P)

Shell International, Carel van Bylandtlaan 16, The Hague, the Netherlands.

Bernd Marx (B)

Shell International, Carel van Bylandtlaan 16, The Hague, the Netherlands.

Carmen Chew (C)

Neurobusiness Behavioural Laboratory, Monash University Malaysia, Building 6B, Kuala Lumpur, Malaysia.

Andrew Tucker (A)

Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, 18 Innovation Walk, Clayton, VIC, Australia.

Shamsul Haque (S)

Jeffrey Cheah School of Medicine and Health Sciences, Department of Psychology, Monash University Malaysia, Jalan Lagoon Selatan, 47500 Bandar Sunway, Selangor Darul Ehsan, Malaysia.

Alexandre Schaefer (A)

Neurobusiness Behavioural Laboratory, Monash University Malaysia, Building 6B, Kuala Lumpur, Malaysia.

Mark E Howard (ME)

Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, 18 Innovation Walk, Clayton, VIC, Australia; Institute for Breathing and Sleep, Department of Respiratory and Sleep Medicine, Austin Health, 145 Studley Road, PO Box 5555, Heidelberg, VIC, Australia. Electronic address: mark.howard@austin.org.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH